Mikael Lantz

683 total citations
16 papers, 461 citations indexed

About

Mikael Lantz is a scholar working on Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, Mikael Lantz has authored 16 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Endocrinology, Diabetes and Metabolism, 4 papers in Pathology and Forensic Medicine and 3 papers in Epidemiology. Recurrent topics in Mikael Lantz's work include Thyroid Disorders and Treatments (13 papers), Thyroid Cancer Diagnosis and Treatment (7 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). Mikael Lantz is often cited by papers focused on Thyroid Disorders and Treatments (13 papers), Thyroid Cancer Diagnosis and Treatment (7 papers) and Growth Hormone and Insulin-like Growth Factors (5 papers). Mikael Lantz collaborates with scholars based in Sweden, Australia and United Kingdom. Mikael Lantz's co-authors include Bengt Hallengren, Göran Wallin, Mirna Abraham‐Nordling, Jan Calissendorff, Peter Åsman, Tereza Planck, Ove Törring, Gun Jörneskog, Bengt Andréasson and Lars Grennert and has published in prestigious journals such as European Journal of Endocrinology, Thyroid and Frontiers in Endocrinology.

In The Last Decade

Mikael Lantz

16 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikael Lantz Sweden 10 327 200 51 50 48 16 461
G Kahaly Germany 10 354 1.1× 279 1.4× 79 1.5× 117 2.3× 92 1.9× 18 499
Silvia Perrino Italy 9 284 0.9× 65 0.3× 88 1.7× 42 0.8× 17 0.4× 10 444
L. L. Seah Singapore 9 222 0.7× 253 1.3× 30 0.6× 50 1.0× 98 2.0× 13 391
Massimo Panicucci Italy 6 449 1.4× 515 2.6× 33 0.6× 106 2.1× 163 3.4× 8 609
Aldo Pinchera Italy 7 346 1.1× 94 0.5× 58 1.1× 19 0.4× 7 0.1× 8 420
Noortje I. Regensburg Netherlands 9 232 0.7× 346 1.7× 22 0.4× 171 3.4× 110 2.3× 10 484
Dominika Januś Poland 10 136 0.4× 75 0.4× 73 1.4× 14 0.3× 24 0.5× 50 413
Deborah Alcorn United States 10 54 0.2× 161 0.8× 62 1.2× 117 2.3× 63 1.3× 22 460
Heves Kırmızıbekmez Türkiye 9 68 0.2× 67 0.3× 48 0.9× 10 0.2× 27 0.6× 38 263
Yuka Kosuga Japan 6 250 0.8× 59 0.3× 38 0.7× 12 0.2× 3 0.1× 8 316

Countries citing papers authored by Mikael Lantz

Since Specialization
Citations

This map shows the geographic impact of Mikael Lantz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikael Lantz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikael Lantz more than expected).

Fields of papers citing papers by Mikael Lantz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikael Lantz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikael Lantz. The network helps show where Mikael Lantz may publish in the future.

Co-authorship network of co-authors of Mikael Lantz

This figure shows the co-authorship network connecting the top 25 collaborators of Mikael Lantz. A scholar is included among the top collaborators of Mikael Lantz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikael Lantz. Mikael Lantz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Calissendorff, Jan, Per Karkov Cramon, Bengt Hallengren, et al.. (2023). Long-Term Outcome of Graves' Disease: A Gender Perspective. Women s Health Reports. 4(1). 487–496. 4 indexed citations
2.
Udumyan, Ruzan, Gabriel Sjölin, Jan Calissendorff, et al.. (2023). Fracture Incidence in Graves' Disease: A Population-Based Study. Thyroid. 33(11). 1349–1357. 4 indexed citations
3.
Planck, Tereza, Mikael Lantz, Petros Perros, et al.. (2021). Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients: A 2020 THESIS Questionnaire Survey of Members of the Swedish Endocrine Society. Frontiers in Endocrinology. 12. 795111–795111. 15 indexed citations
4.
Planck, Tereza, Vijayachitra Modhukur, Anna Sundlöv, et al.. (2021). Increased risk of Graves´ophthalmopathy in patients with increasing TRAb after radioiodine treatment and the impact of CTLA4 on TRAb titres. Endocrine. 75(3). 856–864. 4 indexed citations
5.
Lindgren, Ola, Anna Sundlöv, Jan Tennvall, et al.. (2019). The Effect of Radioiodine Treatment on TRAb, Anti-TPO, and Anti-TG in Graves’ Disease. European Thyroid Journal. 8(2). 64–69. 9 indexed citations
6.
Planck, Tereza, et al.. (2018). Study of Deiodinase Type 2 Polymorphisms in Graves’ Disease and Ophthalmopathy in a Swedish Population. European Thyroid Journal. 7(6). 289–293. 2 indexed citations
7.
Planck, Tereza, Hemang Parikh, Kristoffer Ström, et al.. (2014). Smoking Induces Overexpression of Immediate Early Genes in Active Graves' Ophthalmopathy. Thyroid. 24(10). 1524–1532. 30 indexed citations
8.
Lantz, Mikael, Tereza Planck, Peter Åsman, & Bengt Hallengren. (2014). Increased TRAb and/or Low Anti-TPO Titers at Diagnosis of Graves’ Disease are Associated with an Increased Risk of Developing Ophthalmopathy after Onset. Experimental and Clinical Endocrinology & Diabetes. 122(2). 113–117. 43 indexed citations
9.
Roth, Bodil, et al.. (2013). A cross-sectional study of subclinical and clinical thyroid disorders in women with microscopic colitis compared to controls. Scandinavian Journal of Gastroenterology. 48(12). 1414–1422. 12 indexed citations
10.
Abraham‐Nordling, Mirna, Ove Törring, Mikael Lantz, et al.. (2011). Incidence of hyperthyroidism in Sweden. European Journal of Endocrinology. 165(6). 899–905. 177 indexed citations
11.
Svensson, Johan, Cecilia Oderup, Caroline Piercey Åkesson, et al.. (2011). Maternal Autoimmune Thyroid Disease and the Fetal Immune System. Experimental and Clinical Endocrinology & Diabetes. 119(7). 445–450. 8 indexed citations
12.
Abraham‐Nordling, Mirna, Göran Wallin, Frank Träisk, et al.. (2010). Thyroid-associated ophthalmopathy; quality of life follow-up of patients randomized to treatment with antithyroid drugs or radioiodine. European Journal of Endocrinology. 163(4). 651–657. 26 indexed citations
13.
Hallengren, Bengt, Mikael Lantz, Bengt Andréasson, & Lars Grennert. (2009). Pregnant Women on Thyroxine Substitution Are Often Dysregulated in Early Pregnancy. Thyroid. 19(4). 391–394. 62 indexed citations
14.
Lantz, Mikael, Mirna Abraham‐Nordling, Johan Svensson, Göran Wallin, & Bengt Hallengren. (2008). Immigration and the incidence of Graves' thyrotoxicosis, thyrotoxic multinodular goiter and solitary toxic adenoma. European Journal of Endocrinology. 160(2). 201–206. 21 indexed citations
15.
Abraham‐Nordling, Mirna, Ove Törring, Mikael Lantz, et al.. (2008). Incidence of hyperthyroidism in Stockholm, Sweden, 2003–2005.. European Journal of Endocrinology. 158(6). 823–827. 37 indexed citations
16.
Olsson, Inge, Arne Egesten, Urban Gullberg, et al.. (1986). The biosynthesis of neutrophil and eosinophil granule proteins.. PubMed. 24(2). 89–97. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026